Epignostix
1 known investors
Epignostix develops software for molecular tumour classification using DNA methylation profiling and machine learning, aimed at improving diagnostic accuracy for cancer patients. It serves oncology and clinical care, focusing on precision molecular diagnostics through research, development, certification, and marketing of its classifiers.
Investors · 1
Frequently asked questions
- What does Epignostix do?
- Epignostix develops software for molecular tumour classification using DNA methylation profiling and machine learning, aimed at improving diagnostic accuracy for cancer patients. It serves oncology and clinical care, focusing on precision molecular diagnostics through research, development, certification, and marketing of its classifiers.
- Who are Epignostix's investors?
- Epignostix's investors include LBBW Venture Capital GmbH.